Phaos Technology Holdings (Cayman) (POAS) Current Leases (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Current Leases of $40368.0 for Q4 2025, down 50.56% on a QoQ basis from $81649.5 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Current Leases (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Current Leases history runs 2 years deep, the most recent figure standing at $40368.0 for Q4 2025.

Quarterly Current Leases changed N/A year-over-year to $40368.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $40368.0 (changed N/A YoY) and the FY2025 annual result came in at $81724.3, down 17.11% from the prior year.
Current Leases was $40368.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $81649.5 in the prior quarter.
Across five years, Current Leases topped out at $98591.3 in Q2 2024 and bottomed at $40368.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	183.67 Bn	176.38 Bn	6.27 Bn	-
2	Stryker	128.91 Bn	126.03 Bn	3.81 Bn	-
3	Medtronic	108.84 Bn	99.62 Bn	6.41 Bn	-
4	Boston Scientific	68.57 Bn	67.12 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.68 Bn	45.01 Bn	1.29 Bn	24.30 Mn
6	Dexcom	28.42 Bn	27.31 Bn	750.30 Mn	20.50 Mn
7	GE HealthCare Technologies	28.38 Bn	26.09 Bn	1.98 Bn	-
8	Smith & Nephew	26.94 Bn	26.36 Bn	-	-
9	Koninklijke Philips	25.50 Bn	22.38 Bn	2.07 Bn	-
10	Phaos Technology Holdings (Cayman)	6.24 Mn	6.18 Mn	-	40,368.00

Download Data